Evidence map›Paper›PMID 23623389›Full record

ArticleAmerican journal of human genetics2013

Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia.

Kazuya Kashiyama, Yuka Nakazawa, Daniela T Pilz, Chaowan Guo, Mayuko Shimada, Kensaku Sasaki, Heather Fawcett, Jonathan F Wing, Susan O Lewin, Lucinda Carr and 16 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in American journal of human genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 123 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed, 1 pooled it
12.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

123 citing papers in PubMed, 1 synthesis or guideline pooled it, 204 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. DNA repair and anti-cancer mechanisms in the long-lived bowhead whale.bioRxiv : the preprint server for biology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Model Systems to Study the Mechanism of Vascular Aging.International journal of molecular sciences · 2023
    Review
  15. Article
  16. Article
  17. Review
  18. Deep intronic founder mutations identified in theProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  19. Review
  20. Case report: Variants in theFrontiers in genetics · 2023
    Article

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 8 institutions in 4 countries.

Kazuya KashiyamaDepartment of Plastic and Reconstructive Surgery, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.
Yuka Nakazawa
Daniela T Pilz
Chaowan Guo
Mayuko Shimada
Kensaku Sasaki
Heather Fawcett
Jonathan F Wing
Susan O Lewin
Lucinda Carr
Tao-Sheng Li
Koh-ichiro Yoshiura
Atsushi Utani
Akiyoshi Hirano
Shunichi Yamashita
Danielle Greenblatt
Tiziana Nardo
Miria Stefanini
David McGibbon
Robert Sarkany
Hiva Fassihi
Yoshito Takahashi
Yuji Nagayama
Norisato Mitsutake
Alan R Lehmann
Tomoo Ogi
Nagasaki University · JPSt Thomas' Hospital · GBUniversity of Sussex · GBIstituto di Genetica Molecolare · ITFukushima Medical University · JPGreat Ormond Street Hospital · GBUniversity Hospital of Wales · GBUniversity of Utah · US

Funding

Department of Health
6 · The paper itself

Abstract

Cockayne syndrome (CS) is a genetic disorder characterized by developmental abnormalities and photodermatosis resulting from the lack of transcription-coupled nucleotide excision repair, which is responsible for the removal of photodamage from actively transcribed genes. To date, all identified causative mutations for CS have been in the two known CS-associated genes, ERCC8 (CSA) and ERCC6 (CSB). For the rare combined xeroderma pigmentosum (XP) and CS phenotype, all identified mutations are in three of the XP-associated genes, ERCC3 (XPB), ERCC2 (XPD), and ERCC5 (XPG). In a previous report, we identified several CS cases who did not have mutations in any of these genes. In this paper, we describe three CS individuals deficient in ERCC1 or ERCC4 (XPF). Remarkably, one of these individuals with XP complementation group F (XP-F) had clinical features of three different DNA-repair disorders--CS, XP, and Fanconi anemia (FA). Our results, together with those from Bogliolo et al., who describe XPF alterations resulting in FA alone, indicate a multifunctional role for XPF.

Indexed as

PhenotypeAmino Acid SequenceBase SequenceCockayne SyndromeDNA-Binding ProteinsDNA PrimersEndonucleasesFanconi AnemiaFatal OutcomeFemaleGenetic Predisposition to DiseaseHumansMaleMolecular Sequence DataSequence Analysis, DNAXeroderma PigmentosumDNA-Binding ProteinsDNA PrimersEndonucleasesERCC1 protein, humanxeroderma pigmentosum group F protein

Identifiers

PMID23623389
PMCPMC3644632
OpenAlexW2010787386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.